New Therapy for Early-Stage Polycystic Kidney Disease: Combination of Difelikefalin and Tolvaptan: TH-PO411

Juan Gao, LSU Health Sciences Center - New Orleans
Kara Johnson, LSU Health Sciences Center - New Orleans
Madison G. Haggard, LSU Health Sciences Center - New Orleans
Ian B. Denys, LSU Health Sciences Center - New Orleans
Mihran V. Naljayan, LSU Health Sciences Center - New Orleans
Daniel Kapusta, LSU Health Sciences Center - New Orleans

TH-PO411

Abstract

American Society of Nephrology - Kidney Week; November 1 - 5, 2023; Philadelphia, PA